Page 1 E N G LIS H D E U T S C H ITA LIA N O F R A N Ç A IS E S P ...

More documents

Recommendations

Info

Distribution of Percent Change in BAP Levels Following 12 Months Therapy with Estrogen/Progestin (HRT) or Placebo (CTL) At 12 months, subjects in HRT had gained LSBMD compared to CTL (p
10 HRT Study - Linear Regression of the % change in LSBMD and BAP from Baseline to 12 months Contingency table analysis showed that a ≥ 25% decrease in BAP at 12 months was significantly associated (p < 0.0001) with a positive skeletal response to HRT (gain in BMD) at 12 months. The binomial (second order approximation) 85% confidence intervals for the sensitivity and specificity of using a 25% decrease in BAP for predicting a response to HRT are: Sensitivity = 77% (95% CI 75%, 82%); Specificity = 61% (95% CI 41%, 78%). These results indicate that the % change in BAP concentration can be used to predict the degree of skeletal response (BMD) to HRT treatment. LSBMD Percent Change to 12 months 15.0% 10.0% 5.0% 0.0% -5.0% -10.0% -15.0% -60.0% -40.0% -20.0% ASS<strong>IS</strong>TANCE To place an order or for technical assistance, please contact a Quidel Representative at 800-524-6318 or 408-616-4301, Monday through Friday, between 8:00 a.m. and 5:00 p.m., Pacific Time. Orders may also be placed by fax at 408-616-4310. For services outside the U.S., please contact your local distributor. y = -0.060x + 0.011 r = 0.51 p < 0.001 0.0% 20.0% 40.0% 60.0% BAP Percent Change to 12 months
Page 1 and 2: ��
Page 3 and 4: q Coated Strips Part 4660 12 each P
Page 5 and 6: Representative Standard Curve Stand
Page 7 and 8: Accuracy Comparative studies were p
Page 9: 8 Proportion of Population (%) ≤
Page 13 and 14: MITGELIEFERTE REAGENZIEN UND MATERI
Page 15 and 16: Hinzugeben der Stopplösung und Abl
Page 17 and 18: Störsubstanzen Die folgenden Subst
Page 19 and 20: 18 Anteil an der Population (%) Ver
Page 21 and 22: Prognose der skelettalen Reaktion:
Page 23 and 24: REAGENTI E MATERIALI FORNITI 96 sag
Page 25 and 26: Arresto/Lettura 11. Aggiungere a ci
Page 27 and 28: Sostanze interferenti Le seguenti s
Page 29 and 30: 28 Proporzione della popolazione (%
Page 31 and 32: Previsione della risposta scheletri
Page 33 and 34: RÉACTIFS ET MATÉRIAUX FOURNIS 96
Page 35 and 36: Arrêt/Lecture 11. Ajouter 100 µL
Page 37 and 38: phosphatase alcaline osseuse En cou
Page 39 and 40: 38 Proportion de la population (%)
Page 41 and 42: Prédiction de la réaction osseuse
Page 43 and 44: REACTIVOS Y MATERIALES PROPORCIONAD
Page 45 and 46: Parada/lectura 11. Añada 100 µL d
Page 47 and 48: Sustancias que interfieren Se anali
Page 49 and 50: 48 Proporción de población (%) Di
Page 51 and 52: Previsión de la respuesta esquelé
Page 53 and 54: REAGENTES E MATERIAIS FORNECIDOS 96
Page 55 and 56: Parar/Ler 11. Adicionar 100 µL de
Page 57 and 58: Substâncias interferentes As subst
Page 59 and 60: 58 Proporção da População (%) D
Page 61 and 62:
60 Percentagem de alteração na LS
Page 63 and 64:
LEVEREDE MATERIALER OG REAGENSER 96
Page 65 and 66:
13. Kvantificeringssoftware med en
Page 67 and 68:
Lægemiddelinterferenser Diverse ko
Page 69 and 70:
Overvågning af behandlingen: En ve
Page 71 and 72:
70 LSBMD procentændring til 12 mdr
Page 73 and 74:
MEDFÖLJANDE REAGENSER OCH MATERIAL
Page 75 and 76:
KVALITETSKONTROLL Analyscertifikate
Page 77 and 78:
Läkemedelsinterferens Olika koncen
Page 79 and 80:
Användning av Metra-BAP för över
Page 81 and 82:
80 LSBMD % förändring till 12 må
Page 83 and 84:
ΠΑΡΕΧΟΜΕΝΑ ΑΝΤΙΔΡΑ
Page 85 and 86:
Επώαση υποστρώματο
Page 87 and 88:
Ακρίβεια Η ακρίβει
Page 89 and 90:
88 30,0% 25,0% 20,0% 15,0% 10,0% 5,
Page 91 and 92:
90 30,0% 25,0% 20,0% 15,0% 10,0% Κ
Page 93:
REFERENCES LITERATURVERWEISE BIBLIO
show all

Page 1 E N G LIS H D E U T S C H ITA LIA N O F R A N Ç A IS E S P ...

Create successful ePaper yourself

Delete template?

Save as template?